Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.
Differentiation of bone marrow stromal cells into schwann-like cells using dihydrotestosterone combined with a classical induction method.
Patient Management Problem-Preferred Responses.
Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.
A mouse model for testing remyelinating therapies.
Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
Lubrini et al.'s study, "The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis".
Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.
Effect of Chronic Medical Conditions in Veterans with Multiple Sclerosis on Long-Term Disability.
Disease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.
The restorative role of annexin A1 at the blood-brain barrier.
Relevance of biomarkers in disease progression in multiple sclerosis.
Volumetric and Shape Analysis of the Thalamus and Striatum in Amnestic Mild Cognitive Impairment.
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies.
Neurodegeneration in MS and NMO: The Eye and the Blood.
Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.
Neurodegeneration in MS and NMO: The Eye and the Blood.
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.
Lack of pathogenicity of immunodominant T and B cell determinants of the nicotinic acetylcholine receptor epsilon-chain.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-Sparing Potential.
Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
Hydrogen sulfide protects against cognitive impairment induced by hepatic ischemia and reperfusion via attenuating neuroinflammation.
Tolerogenic Vaccination with MOG/VitD Overcomes Aggravating Effect of C. albicans in Experimental Encephalomyelitis.
Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
Pages
« first
‹ previous
…
748
749
750
751
752
753
754
755
756
…
next ›
last »